Patent ductus arteriosus in the preterm infant: To treat or not to treat?

Journal of Perinatology

Volumn 30, Issue SUPPL. 1, 2010, Pages

  Noori, S ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

ibuprofen; indomethacin; ligation; neonate; PDA

Indexed keywords

IBUPROFEN; INDOMETACIN; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR;

BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; HEART SURGERY; HUMAN; HYPERBILIRUBINEMIA; INTESTINE PERFORATION; KIDNEY DISEASE; LUNG DYSPLASIA; LUNG HEMORRHAGE; NECROTIZING ENTEROCOLITIS; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PULMONARY HYPERTENSION; WATCHFUL WAITING;

BLOOD CIRCULATION; CASE MANAGEMENT; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LIGATION; MONITORING, PHYSIOLOGIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STANDARD OF CARE; TREATMENT OUTCOME; WATCHFUL WAITING;

EID: 77957577056     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.97     Document Type: Conference Paper

References (64)

1. Noori S, Seri I. The VLBW neonate with a hemodynamically significant patent ductus arteriosus during the first postnatal week. In: Kleinman CS, Seri I (eds). Hemodynamics and Cardiology. Neonatal Questions and Controversies. Saunders Elsevier: Philadelphia, PA, 2008, p 179.
2. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006;26: S14-S18.
3. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113-1121.
4. Noori S, Seri I. Treatment of the patent ductus arteriosus: when, how and for how long? J Pediatr 2009;155:774-776.
5. Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 2004;16:146-151.
6. Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007;92: F498-F502.
7. Knight DB, Laughon MM. Evidence for active closure of patent ductus arteriosus in very preterm infants. J Pediatr 2008;152:446-447.
8. Van Overmeire B. Patent ductus arteriosus: how aggressive should we be? Neonatology 2007;91:318.
9. Clyman RI, Chorne N. Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007;150:216-219.
10. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010;30(4):241-252.
11. Alpan G, Scheerer R, Bland R, Clyman R. Patent ductus arteriosus increases lung fluid filtration in preterm lambs. Pediatr Res 1991;30:616-621.
12. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999;104:1345-1350.
13. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-610.
14. Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr 1994;125:270-277.
15. Perlman JM, Hill A, Volpe JJ. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: ductal steal in the premature newborn infant. J Pediatr 1981;99:767-771.
16. Lipman B, Serwer GA, Brazy JE. Abnormal cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatrics 1982;69:778-781.
17. Martin CG, Snider AR, Katz SM, Peabody JL, Brady JP. Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosus. J Pediatr 1982;101:587-593.
18. Deeg KH, Gerstner R, Brandl U, Bundscherer F, Zeilinger G, Harai G et al. Doppler sonographic flow parameter of the anterior cerebral artery in patent ductus arteriosus of the newborn infant compared to a healthy control sample. Klin Padiatr 1986;198:463-470.
19. Ichihashi K, Shiraishi H, Endou H, Kuramatsu T, Yano S, Yanagisawa M. Cerebral and abdominal arterial hemodynamics in preterm infants with patent ductus arteriosus. Acta Paediatr Jpn 1990;32:349-356.
20. Lemmers PM, Toet MC, van Bel F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics 2008;121:142-147.
21. Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000;82: F188-F194.
22. Dykes FD, Lazzara A, Ahmann P, Blumenstein B, Schwartz J, Brann AW. Intraventricular hemorrhage: a prospective evaluation of etiopathogenesis. Pediatrics 1980;66:42-49.
23. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;75: F183-F186. (Pubitemid 126439147)
24. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002 Issue 3. Art. no.: CD000174..
25. Coombs RC, Morgan ME, Durbin GM, Booth IW, McNeish AS. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990;65:1067-1071.
26. Shimada S, Kasai T, Hoshi A, Murata A, Chida S. Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int 2003;45:255-262.
27. Baylen BG, Ogata H, Ikegami M, Jacobs HC, Jobe AH, Emmanouilides GC. Left ventricular performance and regional blood flows before and after ductus arteriosus occlusion in premature lambs treated with surfactant. Circulation 1983;67:837-843.
28. Clyman RI, Mauray F, Heymann MA, Roman C. Cardiovascular effects of patent ductus arteriosus in preterm lambs with respiratory distress. J Pediatr 1987;111:579-587. (Pubitemid 17140540)
29. Meyers RL, Alpan G, Lin E, Clyman RI. Patent ductus arteriosus, indomethacin, and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr Res 1991;29:569-574.
30. McCurnin D, Clyman RI. Effects of a patent ductus arteriosus on postprandial mesenteric perfusion in premature baboons. Pediatrics 2008;122: e1262-e1267.
31. Ryder RW, Shelton JD, Guinan ME. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980;112:113-123.
32. Dollberg S, Lusky A, Reichman B. Ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr 2005;40:184-188.
33. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966-1972.
34. Clyman RI, Saha S, Jobe A, Oh W. Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice. J Pediatr 2007;150:46-50.
35. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006;26:93-99.
36. Paquette L, Friedlich P, Ramanathan R, Seri I. Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates. J Perinatol 2006;26:486-492.
37. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004;114:1649-1657.
38. Ambat MT, Ostrea Jr EM, Aranda JV. Effect of ibuprofen L-lysinate on bilirubin binding to albumin as measured by saturation index and horseradish peroxidase assays. J Perinatol 2008;28:287-290.
39. Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1939-1944.
40. Bellini C, Campone F, Serra G. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. CMAJ 2006;174:1843-1844.
41. Rheinlaender C, Helfenstein D, Walch E, Berns M, Obladen M, Koehne P. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants. Acta Paediatr 2009;98:36-42.
42. Zecca E, Romagnoli C, De Carolis MP, Costa S, Marra R, De Luca D. Does Ibuprofen increase neonatal hyperbilirubinemia? Pediatrics 2009;124:480-484.
43. Berns M, Toennessen M, Koehne P, Altmann R, Obladen M. Ibuprofen augments bilirubin toxicity in rat cortical neuronal culture. Pediatr Res 2009;65:392-396.
44. Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwé W, Jespers A et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1945-1949.
45. Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Ann Thorac Surg 2006;81:231-234.
46. Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 1996;128:601-607.
47. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005;90: F235-F239.
48. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009;123: e138-e144.
49. Herrman K, Bose C, Lewis K, Laughon M. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 2009;94: F48-F50.
50. Zbar RI, Chen AH, Behrendt DM, Bell EF, Smith RJ. Incidence of vocal fold paralysis in infants undergoing ligation of patent ductus arteriosus. Ann Thorac Surg 1996;61:814-816.
51. Benjamin JR, Smith PB, Cotten CM, Jaggers J, Goldstein RF, Malcolm WF. Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants. J Perinatol 2010;30(6):408-413.
52. Moin F, Kennedy KA, Moya FR. Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol 2003;20:313-320.
53. Noori S, Friedlich P, Seri I, Wong P. Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants. J Pediatr 2007;150:597-602.
54. Teixeira LS, Shivananda SP, Stephens D, Van Arsdell G, McNamara PJ. Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. J Perinatol 2008;28:803-810.
55. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007;150:229-234.
56. Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007;119:1165-1174.
57. Madan JC, Kendrick D, Hagadorn JI, Frantz III ID. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 2009;123:674-681.
58. Loeliger M, Inder TE, Dalitz PA, Cain S, Camm EJ, Yoder B et al. Developmental and neuropathological consequences of ductal ligation in the preterm baboon. Pediatr Res 2009;65:209-214.
59. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989;320:1511-1516.
60. Clyman R, Cassady G, Kirklin JK, Collins M, Philips III JB. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 2009;154:873-876.
61. McCurnin D, Seidner S, Chang LY, Waleh N, Ikegami M, Petershack J et al. Ibuprofeninduced patent ductus arteriosus closure: physiologic, histologic, and biochemical effects on the premature lung. Pediatrics 2008;121:945-956.
62. Chang LY, McCurnin D, Yoder B, Shaul PW, Clyman RI. Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res 2008;63:299-302.
63. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-779.
64. Camo KB, Evans N, Paradisis M. Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography. J Pediatr 2009;155:819-822.